ArunA Bio is engaged in advancing a new class of cell-free biologics, exosomes, for the treatment of central nervous system (CNS) and neurodegenerative disorders and leveraging a platform to optimize the delivery of RNAs, antibodies, genes and small molecules. Using the platform, the Company strives to improve outcomes for CNS cancers, neurodegenerative, genetic and rare diseases.